3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 23 0 0 0 0 0 0 0999 V2000
-2.7326 0.2777 0.3071 S 0 0 0 0 0 0 0 0 0 0 0 0
0.9933 -1.9877 0.0771 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0870 -1.0792 0.6808 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1931 1.2064 1.2830 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3071 -1.7343 -0.3417 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0641 1.0032 -0.4706 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6029 0.1939 -1.0524 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3499 -0.4202 -0.5814 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8845 0.2111 -0.3340 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7018 -0.8255 0.0815 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4127 1.5084 -0.4059 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0375 -0.6748 0.4418 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7558 1.6970 -0.0506 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5511 0.6241 0.3654 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0639 -0.4061 -1.8434 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.4433 1.2110 -1.4222 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8074 2.3507 -0.7257 H 1 0 0 0 0 0 0 0 0 0 0 0
3.6458 -1.5117 0.7625 H 1 0 0 0 0 0 0 0 0 0 0 0
3.1853 2.6944 -0.0989 H 1 0 0 0 0 0 0 0 0 0 0 0
4.5892 0.8027 0.6347 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.9838 1.9928 -0.7350 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5924 0.4362 -1.1451 H 0 0 0 0 0 0 0 0 0 0 0 0
1 3 2 0 0 0 0
1 4 2 0 0 0 0
1 6 1 0 0 0 0
1 7 1 0 0 0 0
2 5 1 0 0 0 0
2 10 1 0 0 0 0
5 8 2 0 0 0 0
6 21 1 0 0 0 0
6 22 1 0 0 0 0
7 8 1 0 0 0 0
7 15 1 0 0 0 0
7 16 1 0 0 0 0
8 9 1 0 0 0 0
9 10 1 0 0 0 0
9 11 2 0 0 0 0
10 12 2 0 0 0 0
11 13 1 0 0 0 0
11 17 1 0 0 0 0
12 14 1 0 0 0 0
12 18 1 0 0 0 0
13 14 2 0 0 0 0
13 19 1 0 0 0 0
14 20 1 0 0 0 0
M ISO 4 17 2 18 2 19 2 20 2
4. 国际命名与标识
4.1 IUPAC Name
(4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide
4.2 InChl
InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)/i1D,2D,3D,4D
4.3 InChlKey
UBQNRHZMVUUOMG-RHQRLBAQSA-N
4.4 Canonical SMILES
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
4.5 lsomeric SMILES
[2H]C1=C(C(=C2C(=C1[2H])C(=NO2)CS(=O)(=O)N)[2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病